rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2006-8-24
|
pubmed:abstractText |
Retroperitoneal fibrosis is a severe disease that affects the ureters, causing renal insufficiency in three-quarters of patients. The optimal treatment is far from being established.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0931-0509
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2485-90
|
pubmed:dateRevised |
2007-8-17
|
pubmed:meshHeading |
pubmed-meshheading:16702201-Adult,
pubmed-meshheading:16702201-Aged,
pubmed-meshheading:16702201-Antineoplastic Agents, Hormonal,
pubmed-meshheading:16702201-Azathioprine,
pubmed-meshheading:16702201-Female,
pubmed-meshheading:16702201-Follow-Up Studies,
pubmed-meshheading:16702201-Glucocorticoids,
pubmed-meshheading:16702201-Humans,
pubmed-meshheading:16702201-Immunosuppressive Agents,
pubmed-meshheading:16702201-Male,
pubmed-meshheading:16702201-Middle Aged,
pubmed-meshheading:16702201-Nephrostomy, Percutaneous,
pubmed-meshheading:16702201-Prosthesis Implantation,
pubmed-meshheading:16702201-Recurrence,
pubmed-meshheading:16702201-Retroperitoneal Fibrosis,
pubmed-meshheading:16702201-Retrospective Studies,
pubmed-meshheading:16702201-Stents,
pubmed-meshheading:16702201-Tamoxifen,
pubmed-meshheading:16702201-Time Factors,
pubmed-meshheading:16702201-Treatment Outcome,
pubmed-meshheading:16702201-Ureter,
pubmed-meshheading:16702201-Ureteral Obstruction
|
pubmed:year |
2006
|
pubmed:articleTitle |
Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches.
|
pubmed:affiliation |
Divisione di Nefrologia e Dialisi, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena Milano, Italy. gmoroni@policlinico.mi.it
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|